Previous year, EUROIMMUN launched the Anti-Zika Virus ELISA IgA. It had turned out that specific anti-Zika virus IgA antibodies against the non-structural protein 1 (NS1) could serve as alternative indicators of acute infection phase if specific IgM antibodies were not detectable. Particularly when patients, who already have had a first contact with a flavivirus (infection […]
EUROIMMUN now offers a new ELISA for the detection of IgA antibodies for the diagnosis of Zika infections. But why is this necessary? Determination of anti-Zika virus IgA may help in the diagnosis of acute Zika virus infections if specific IgM antibodies are not measurable. Primary and secondary immune response in Zika virus infections Usually, IgM antibodies
Press release Luebeck, April 6th 2017 Today EUROIMMUN and Roche announced that they have entered into an option agreement under which Roche gains access to intellectual property in the field of Zika virus immunodiagnostics assigned to EUROIMMUN. In January 2016, EUROIMMUN became the first company in the world to launch antibody tests that are capable
In 2016, the number of whooping cough cases has reached a worrying record in Germany – 22,000 lab confirmed cases were reported to the Robert-Koch-Institute (RKI). In the previous year there were 14,000 cases and more than 1,500 patients have already been registered in 2017 (as of February 9th, 2017). Whooping cough is caused by
Earlier this year, EUROIMMUN announced the availability of the first serological test systems for diagnostics of Zika virus infections. The infectious disease had rapidly spread in Latin America, especially in Brazil, during the past year. Suspicion regarding a link between the virus infections and the increased rate of malformations of newborns’ heads (microcephaly) precipitated concerns
